Alternatives to AIDGenomics

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.